IQSM:NYE-Iq Candriam ESG U.S. Mid Cap Equity ETF (USD)

ETF | Others |

Last Closing

USD 32.784

Change

+0.06 (+0.17)%

Market Cap

N/A

Volume

700.00

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-12-23 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
SOJE Southern Company (The) Series ..

-0.10 (-0.52%)

USD 65.72B
JEPI JPMorgan Equity Premium Income..

+0.19 (+0.33%)

USD 37.61B
DFAC Dimensional U.S. Core Equity 2..

+0.16 (+0.46%)

USD 33.40B
SGOV iShares® 0-3 Month Treasury B..

+0.02 (+0.02%)

USD 28.50B
JPST JPMorgan Ultra-Short Income ET..

N/A

USD 28.13B
DTB DTE Energy Company 2020 Series

-0.03 (-0.16%)

USD 26.58B
GBTC Grayscale Bitcoin Trust (BTC)

-2.76 (-3.61%)

USD 21.47B
JAAA Janus Detroit Street Trust - J..

-0.22 (-0.43%)

USD 16.06B
AVUV Avantis® U.S. Small Cap Value..

-0.02 (-0.02%)

USD 15.95B
DFUS Dimensional U.S. Equity ETF

+0.35 (+0.54%)

USD 13.15B

ETFs Containing IQSM

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 8.87% 55% F 60% D-
Dividend Return 0.88% 15% F 12% F
Total Return 9.75% 52% F 54% F
Trailing 12 Months  
Capital Gain 8.71% 55% F 60% D-
Dividend Return 0.88% 15% F 11% F
Total Return 9.59% 52% F 54% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 7.02% 76% C+ 57% F
Dividend Return 7.38% 75% C 51% F
Total Return 0.37% 25% F 11% F
Risk Return Profile  
Volatility (Standard Deviation) 9.57% 54% F 81% B-
Risk Adjusted Return 77.17% 81% B- 87% B+
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.